Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-19T05:52:02.516Z Has data issue: false hasContentIssue false

Tumefactive Demyelinating Lesions

Published online by Cambridge University Press:  02 December 2014

Mark Hudon
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
Richard Farb
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
A. P. Mitha
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
J. N. Scott
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
D. George
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
A. Hanson
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
M. E. MacRae
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
R. B. Bell
Affiliation:
The Department of Clinical Neurosciences, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Article
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Tan, HM, Chan, LL, Chuah, KL, Goh, NS, Tang, KK. Monophasic, solitary tumefacture demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol. 2004;77(914): 1536.Google Scholar
2. Tsui, EY, Leung, WH, Chan, JH, Cheung, YK, Ng, SH. Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imaging Graph. 2002;26(5): 3436.CrossRefGoogle ScholarPubMed
3. Zagzag, D, Miller, DC, Kleinman, GM, Abati, A, Donnenfeld, H, Budzilovich, GN. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol. 1993; 17(6): 53745.Google Scholar
4. Given, CA, Stevens, BS, Lee, C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol. 2004; 182(1): 1959.Google Scholar
5. Masdeu, JC, Moreira, J, Trasi, S, Visintainer, P, Cavaliere, R, Grundman, M. The open ring. A new imaging sign in demyelinating disease. J Neuroimaging. 1996; 6(2): 1047.Google Scholar
6. He, J, Grossman, RI, Ge, Y, Mannon, LJ. Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol. 2001; 22(4): 6649.Google Scholar
7. Cha, S, Pierce, S, Knopp, EA, Johnson, G, Yang, C, Ton, A, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2001; 22(6): 110916.Google ScholarPubMed
8. Butteriss, DJ, Ismail, A, Ellison, DW, Birchall, D. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol. 2003; 76(909): 6625.Google Scholar
9. Enzinger, C, Strasser-Fuchs, S, Ropele, S, Kapeller, P, Kleinert, R, Fazekas, F. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imagery. Mult Scler. 2005; 11(2): 1359.Google Scholar